Ant Insurance Uses AI to Help Partner Insurers Process 7.25 Million Health Claims in 2024, Up 55% YoY
In 2024, leading insurers in China processed 7.25 million health claims through Ant Insurance, Ant Group's online insurance brokerage platform, marking a 55% year-over-year increase. Total health claim payouts on the platform reached RMB 9.2 billion (USD 1.3 billion). This growth is driven by ongoing innovations in product offerings and user experience, which build trust and meet user needs, while also reflecting the increasing demand for health insurance services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250309812706/en/
Partner insurers processed 7.25 million health claims through Ant Insurance in 2024, up 55% year-over-year. (Photo: Business Wire)
The trend is expected to accelerate as China’s demographic patterns shift. By around 2035, over 400 million people, or more than 30% of the population, will be aged 60 or older, according to projections from China’s National Health Commission. As healthcare needs expand, commercial health insurance is becoming an essential complement to the country's basic medical system.
Ant Group has been leveraging innovative technologies to drive the digital transformation of the healthcare sector, with health insurance playing a key role.
Early in 2018, Ant Insurance introduced Haoyibao, a flagship health insurance product developed in partnership with leading insurers in China. It was the first in the country to offer guaranteed renewal for six consecutive years with payouts of up to RMB 4 million (USD 550,000). Over time, Haoyibao has been continually upgraded to support a wider range of people and health conditions. As a bestselling product, it has helped millions of families manage the financial burden of medical expenses.
With technologies like AI, Ant Insurance has streamlined every step of the insurance process - from product selection and planning to management and claims - making insurance services more accessible to the public.
The GoldenChoice feature uses the Ant Insurance Multi-factor Model (AIMM) to compare and select the best insurance products. Meanwhile, the EasyPick AI insurance planner creates personalized plans for users, helping them avoid overbuying or selecting the wrong coverage. In 2024, the AI-powered EasyClaims solution helped 11 partner insurers streamline the claims process for over 85 health insurance products, with AI handling 96% of the 1.62 million claims analysis requests from policyholders.
Further enhancing insurer capabilities, Ant Insurance launched Ant Bridge in September 2024. This open platform integrates AI models and financial intelligence to help insurers provide real-time, personalized responses to customer inquiries, improving service quality and operational efficiency.
Beyond insurance, Ant Group has been actively contributing to the digital transformation of China’s healthcare industry for over a decade. Since launching the country’s first online hospital appointment booking service in 2014, Ant Group’s Alipay digital platform has been assisting hospitals in developing digital services. As of January 2025, Alipay has connected more than 800 million users with services from over 3,600 hospitals.
In September 2024, Ant Group introduced the AI Healthcare Manager within the Alipay app. Available through voice and text interactions, this tool provides users with access to over 30 services, including doctor mapping, medical report interpretation, in-hospital navigation, and personalized medical advice.
Through these ongoing initiatives, Ant Group is contributing to the more efficient use of limited medical resources, with the aim of supporting greater medical inclusion.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250309812706/en/
Contacts
Media Inquiries
Yinan Duan
duanyinan.dyn@antgroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nexo Announces Landmark Crypto Partnership with Tennis Australia for Australian Open and Summer of Tennis17.12.2025 09:00:00 CET | Press Release
Nexo, the premier digital assets platform, has entered a landmark multi-year global partnership with Tennis Australia, becoming the Official Crypto Partner of the Australian Open and the Summer of Tennis, including the United Cup, Adelaide International, Brisbane International, and Hobart International. This agreement marks the first time a digital asset company has partnered with a Grand Slam tournament, affirming Nexo’s prestige, long-term vision, and leadership at the intersection of elite sport and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216497915/en/ Antoni Trenchev, Co-founder, Nexo, noted: “The Australian Open stands at the intersection of excellence and ambition – precisely where Nexo positions itself. Our partnership reflects a shared commitment to disciplined performance and long-term thinking. We are honored to join Tennis Australia in elevating the sport while showcasing the value of int
Jerrod Chong, Yubico ’ s Chief Operating Officer, appointed as acting CEO17.12.2025 08:05:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and the leading provider of hardware authentication security keys, today announced that Jerrod Chong, Yubico’s current Chief Operating Officer, has been appointed to serve as acting CEO. Mattias Danielsson will be stepping down from his role as CEO of Yubico. "I am very pleased that Jerrod has accepted the role of acting CEO. With his extensive experience in cybersecurity and twelve years in senior leadership at Yubico, I am confident that he will lead Yubico on a continued path of growth and he will ensure Yubico maintains and strengthens its leading position. On behalf of the board, I also want to extend our sincere thanks to Mattias Danielsson for his hard work and significant contributions to Yubico’s development as a respected leader and colleague over sixteen years. We deeply appreciate his commitment to Yubico over the years," says Patrik Tigerschiöld, Chairman of the Board. "Yubico is entering an excitin
VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 08:00:00 CET | Press Release
VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat
Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions17.12.2025 08:00:00 CET | Press Release
Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities. The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape. Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, posture validation, and secure workforce access. The acquisition marks the company's entry into the Zero Trust Workforce Access market and lays the foundation for its identity security division, Specops, to offer a unified appr
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom